Resources

Ancillare provides through publication of articles, white papers, ebooks, and more.

READ MORE →

Featured

Clinical Kitting: More Than Just Packing Boxes

Featured
Why Investigator Sites Shouldn’t Order Ancillary Supplies

Explore All Insights & Results

ARTICLES →

WHITE PAPERS →

INDUSTRY PUBLICATIONS →
EBOOKS →
Services

Learn what Clinical Trial Supply services we offer, how our services are delivered, and how you can benefit from an Ancillare Partnership.

LEARN MORE →

ANCILLARY SUPPLY CHAIN
MANAGEMENT →

MEDICAL CONSULTING →

FOR SPONSORS →
FOR CROs →
Why Ancillare
Because we
…maintain a therapeutically representative portfolio across all phases and stages

…boast established relationships and on-the-ground expertise across 22 strategic depots

…cover all major geographies, with access to all global clinical trial sites

…provide in-house medical staff and dedicated project managers to consult on every project

…offer our services at scale, allowing sponsors and CROs to realize 30%+ cost savings
A TRUSTED BIOPHARMA PARTNER →

EXPERIENCED LEADERSHIP →

GLOBAL REACH →
THERAPEUTIC & MEDICAL EXPERTISE →
ANCILLARE PROFESSIONAL TEAM →
COMPANY OVERVIEW →

Contact Ancillare

Sponsors, CROs and SMOs, fill out the brief questionnaire and we’ll connect you to our development team.
For general inquiries, please contact info@ancillare.com
  • Should be Empty:
Ancillare
  • Why Ancillare
  • Services
  • Resources
  • Contact
  • Careers
  • News & Events
  • Why Ancillare
  • Services
    • For Sponsors
    • For CROs
    • Proven Biopharma Partner
    • Medical Consulting for Ancillary Supplies
    • Ancillary Supply Management
  • Resources
  • Contact
  • Careers
  • News & Events
M
  • Follow
  • Follow
  • Follow
  • Follow
+1 877.474.5656
  • Why Ancillare
  • Services
    • For Sponsors
    • For CROs
    • Proven Biopharma Partner
    • Medical Consulting for Ancillary Supplies
    • Ancillary Supply Management
  • Resources
  • Contact
  • Careers
  • News & Events

Ancillare To Host Ribbon Cutting Ceremony, Unveil Multi-Million Dollar Renovation of Montgomery County Headquarters

May 9, 2023 | Press Release

The company invites staff and the press to tour its new Kitting facility for biopharmaceutical companies and CROs conducting global clinical research.

Horsham, Pa. — May 09, 2023. The Ribbon Cutting event will be by Ancillare on May 25, 2023 from 12-3 p.m. at the company’s headquarters, located at 700 Enterprise Road in Horsham, Pa.

Ancillare is the global leader and only Life Sciences company dedicated to ancillary supply and equipment management for Phase I-IV clinical research.

Renovations to the 80,000 square foot facility began in 2022 with its largest project being the creation of a cGMP compliant Kitting Room. The room will provide clinical kitting services, where custom collection kits are created based on the protocol needs of a particular clinical trial. Ancillare provides the equipment, packaging, instruction manuals, and compliant labeling.

In addition to the Kitting Room buildout, there were many eco-conscious improvements made throughout the facility.

The new Kitting Room joins Ancillare’s distribution and storage center in Horsham, 22 strategic depots located across Europe, South America, and Asia-Pacific, and its corporate office, which is also housed at the 700 Enterprise Road facility.

Jonathan Santomauro, Chief Strategy Officer, said, “Ancillare has always offered Kitting Services to our customers. But the dedicated Kitting Room we have built allows us to respond even faster to the demands of modern clinical research, providing our Sponsors unprecedented speed and flexibility in delivering single customized kits to the patients participating in these ground-breaking clinical trials.”

Ancillare employs over 115 people with employees working throughout Southeast Pennsylvania, across the United States and as far away as the Netherlands. The company plans to grow their workforce by 25% over the next several years.

The event will feature Ancillare’s Founding Partners and Executive Leadership, including Dr. Joanne Santomauro, Jason Monteleone, Jonathan Santomauro, and Frank Santomauro. Leadership Team members will be available for on-site interviews. If interested, the media is asked to contact Courtney Wright, Director of Global Marketing at courtney.wright@ancillare.com or by phone at 215-347-3916.

About Ancillare, LP
Ancillare is the only full-service ancillary supply partner that Life Sciences companies of all sizes, and at all development stages, rely on. From start-up to closeout, and from supply sourcing to equipment reclamation and study dissolution, we are the pioneers in clinical trial ancillary supply consulting and management, experienced in the full spectrum of clinical trial life cycle variables.

The Ancillare Team leverages extensive global buying power, a vast depot network, and subject-matter experts in research, procurement, operations, logistics, and regulatory matters to create tailored ancillary supply and equipment programs for the most demanding Phase I-IV clinical research.
We help executives and investors achieve better operational efficiency at all levels of the trial value chain. Simplifying and streamlining supply processes —that’s our specialty. Reduced costs. Expedited cycle times. Risk well-managed. The benefits are measurable, but the results are invaluable. To learn more, visit us at https://www.ancillare.com

Ancillare Launches Employee Training and Development Program, Offers Tuition Assistance

May 31, 2022 | Press Release

Leading life sciences supply chain organization announces new professional development resources for its staff.

Horsham, Pa. — May 31, 2022. Global Clinical Trial Ancillary Supply Chain (CTASC™) leader Ancillare, LP, the first and only Life Sciences company dedicated to Ancillary Supply Chain for Phase I-IV clinical research, is proud to announce the official launch of Ancillare University, a set of professional development courses for its staff.

Ancillare University includes a variety of resources for professionals at all levels, including Leadership and Executive courses, preparation for Project Management Certifications, Technology training, and more. The program became available to employees earlier this year and is fully accessible to its remote-first workforce.

In addition to the educational resources it offers internally, Ancillare also offers a tuition assistance program for employees advancing their careers through higher education.

“Ancillare University is designed to help our employees build more fulfilling, growth-oriented careers,” said Dr. Joanne Santomauro, Chief Executive Officer. “As an organization built on innovation, it is highly important that we continue to invest in our workforce.”

Ancillare is currently hiring for a variety of roles in Project Management, Clinical Operations, Procurement, Technology, and more. To learn more about open positions and available benefits, visit Ancillare.com/Careers.

About Ancillare, LP
Ancillare is the first and only Life Sciences company dedicated to Clinical Trial Ancillary Supply Chain (CTASC™) for Phase I-IV clinical research. Ancillare arms Sponsors of global clinical trials with customized, end-to-end supply plans, enabling developers of new therapies to optimize their supply chains using streamlined processes, extensive global buying power, a vast depot network, and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s industry-shaping model navigates the complexities of the Clinical Trial Ancillary Supply Chain to reduce both the overall cost and cycle time of clinical trials, and greatly improve operational efficiency across all levels of the value chain.

Ancillare has supported more than 8,000 clinical trials across 550,000 clinical sites in over 100 countries with corporate offices in the United States and the Netherlands, and distribution hubs in Argentina, Brazil, Canada, China, Israel, Japan, South Korea, Mexico, Philippines, Russia, Taiwan, and Ukraine. To learn more, visit Ancillare.com.

Ancillare Joins Decentralized Trials & Research Alliance (DTRA)

Feb 8, 2022 | Press Release

Leading life sciences supply chain organization promotes adoption of decentralized clinical trials alongside fellow industry leaders.

Horsham, Pa. — February 8, 2022. Global Clinical Trial Ancillary Supply Chain (CTASC™) leader Ancillare, LP, the first and only Life Sciences company dedicated to Ancillary Supply Chain for Phase I-IV clinical research, announced today it has joined the Decentralized Trials & Research Alliance (DTRA), an historic alliance of over one hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.

The “Decentralized Trials & Research Alliance (DTRA),” which launched December 2020, is uniting industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.

“Decentralized trials are the future of clinical research, and a well-managed supply chain is foundational to their success,” said Dr. Joanne Santomauro, Chief Executive Officer, Ancillare. “As a member of the DTRA, Ancillare will help pave the way to broader adoption of decentralized trials through awareness and innovation of the global Clinical Trial Ancillary Supply Chain.”

“We are extremely gratified to welcome Ancillare to the ‘Decentralized Trials & Research Alliance,’” said Amir Kalali, MD, founder of several collaborative life science communities, and co-Chair of DTRA. “By advancing decentralized research we can make the clinical trial process more patient-focused, increase trial efficiency and encourage use of technologies. We are excited by Ancillare’s commitment to embracing decentralized trials and to changing the culture that has been the rate limiter to innovation.”

During the COVID-19 pandemic, Ancillare devoted greater focus to its Direct-to-Patient operation, which encompasses the assembly of ready-to-distribute single patient kits needed for decentralized research. The company is now expanding its facilities to accommodate enhanced kitting services for Sponsors conducting decentralized trials.

“Now is the time to share ideas and insights that will chart the future course of clinical trials, accelerating drug development and saving lives – and by taking part in the DTRA, Ancillare is demonstrating its leadership to drive change,” said Craig Lipset, DTRA co-Chair, clinical innovation advisor, and a pioneer in decentralized trials. “We have a responsibility to advance the health of people with unmet medical needs, and by convening stakeholders from pharma companies, regulators, technology leaders and patient communities, we can remove remaining barriers to adoption and impact patients today.”

To learn more about Ancillare’s work to advance clinical research through integrated supply chain strategies, visit Ancillare.com.

About Ancillare, LP
Ancillare is the first and only Life Sciences company dedicated to Clinical Trial Ancillary Supply Chain (CTASC™) for Phase I-IV clinical research. Ancillare arms Sponsors of global clinical trials with customized, end-to-end supply plans, enabling developers of new therapies to optimize their supply chains using streamlined processes, extensive global buying power, a vast depot network, and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s industry-shaping model navigates the complexities of the Clinical Trial Ancillary Supply Chain to reduce both the overall cost and cycle time of clinical trials, and greatly improve operational efficiency across all levels of the value chain.

Ancillare has supported more than 4,000 clinical trials across 200,000 clinical sites over 100 countries with corporate offices in the United States and the Netherlands, and distribution hubs in Argentina, Brazil, Canada, China, Israel, Japan, South Korea, Mexico, Netherlands, Philippines, Russia, Taiwan, and Ukraine. To learn more, visit Ancillare.com.

About DTRA
The Decentralized Trials & Research Alliance (DTRA) was convened to enable collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research. It works to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research methods. Follow DTRA on Twitter and LinkedIn for more information.

Know + Know How: Reengineering Consultative Partnerships in CTASC™ Management

Know + Know How: Reengineering Consultative Partnerships in CTASC™ Management

Feb 1, 2022 | Articles

Today’s clinical research environment requires cooperation and insight across countless organizations, teams, and specialists. More and more, Sponsors are turning to trusted third parties with high levels of expertise to make their trials run effectively.

Collaboration often develops into long-term partnerships, which can produce tremendous value. On the other hand, mismanaged partnerships can also spur frustration and dead ends. A common example is the consultative exchange, which often leaves Sponsors with a wealth of advice — but no path to implementation. Without the operational means to execute the strategy, they are back to square one.

The Strategy to Success

To make the most of consulting engagements, Sponsors should aim to partner with teams that not only demonstrate specialized knowledge, but also the ability to put their own advice into action. The difference between the two can be difficult to spot — but probing for anecdotal examples gives tremendous insight. It is always worth the time to ask prospective partners about the types of challenges they have been brought in to solve, and the specific steps they take to arrive at solutions.

Another indicator of an implementation-oriented partner is use of technology. Whether looking at companies of larger scale who offer full clinical trial management systems, or smaller teams with specialized programs and solutions, Sponsors will benefit far more with robust technologies at their fingertips.

Nuances of Clinical Supply Chain Management

Some aspects of conducting clinical research benefit from highly specialized support. Sourcing and managing ancillary supplies for clinical trials is a prime example. There are countless approaches to outsourcing ancillary supply and equipment management, but some will only place greater burden on the Sponsor when all is said and done.

Ancillare developed the Clinical Trial Ancillary Supply Chain (CTASC™) approach for precisely that reason. While Sponsors need to make informed decisions about their clinical supply chains, they also need support to innovate along the way. The consulting component of CTASC is an invaluable resource for Sponsor teams, particularly in the planning and start-up phases. It bolsters risk management in clinical trials, and ensures that protocol considerations do not take a backseat.

Sponsors can also choose to turn over their ancillary supply chain management entirely, reaping the benefits of an end-to-end solution. A fully managed CTASC means no loose ends after the engagement comes to a close — everything is handled, all the way through to returns, reclamation, and disposition.

CTASC™: a Holistic Solution

Ancillare is reimagining what consultative partnerships in clinical research can be. CTASC makes supply chain expertise practical, with hands-on support to bring entire strategies to fruition. Our engagements are flexible, and we work closely with Sponsors to address and relieve unique pain points. To find out how Ancillare can support your team, contact us today.

Clinical Trials Insights 2021 – Stay Ahead of the Supply Chain

Clinical Trials Insights 2021 – Stay Ahead of the Supply Chain

Jan 17, 2022 | Articles, Featured, Industry Publications

A lack of correct ancillary supplies can be the difference between a clinical trial starting on time or having to delay at significant cost to the sponsor. The Covid-19 pandemic exacerbated what would already be a difficult task of sourcing and purchasing trial equipment. Ancillare CEO Joanne Santomauro explains how the situation developed and how her company stayed ahead of the curve and minimised the impact of shortages in the supply chain.

As published in Clinical Trials Insight 2021

VIEW THE ARTICLE
« Older Entries
Next Entries »

The first and only Life Sciences company dedicated to Ancillary Supply Chain for clinical research.

Categories

  • Articles
  • Ebooks
  • Featured
  • Industry Publications
  • Press Release
  • White Papers

Recent Posts

  • Ancillare Strengthens Global Clinical Trial Supply Chain Leadership with Return of Chad Finney
  • Ancillary Kitting: More than Just Packing Boxes
  • The Hidden Cost of Quality in Clinical Trials and Why Choosing the Right Partner Pays Off
Ancillare

Americas: +1 877.474.5656

Europe: +31 20899 1756

info@ancillare.com

© 2026 Ancillare, LP. All Rights Reserved.

Privacy Policy | Sitemap

Global Headquarters
700 Enterprise Road
Horsham, PA 19044
United States

Ancillare Americas
717 Dickerson Road
North Wales, PA 19454
United States

Ancillare B.V.
Zijdelweg 5-D
1187 ZM Amstelveen
The Netherlands

  • Follow
  • Follow
  • Follow
×